March 1, 2018 09:15 AM EST
Pharma

It’s of­fi­cial: EMA to move in­to per­ma­nent Am­s­ter­dam premis­es in No­vem­ber ‘19 amid con­tin­ued protests from Italy

Amber Tong

Al­most four months af­ter the fate­ful “coin toss” that de­cid­ed the EMA’s re­lo­ca­tion to Am­s­ter­dam, the (cur­rent­ly) Lon­don-based reg­u­la­to­ry agency has for­mal­ly ham­mered out a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

A service from the Financial Times